Shreyaskumar R Patel

15PUBLICATIONS
107CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 01, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas.

Michael S Nakazawa, Ian M Silverman, Victoria Rimkunas

|Sep 25, 2023
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.

Ryan A Denu, Richard K Yang, Alexander J Lazar

|Apr 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).

Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik

|Oct 27, 2022
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma.

James Nguyen, Naoko Takebe, Shivaani Kummar

|Oct 26, 2022
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102).

Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik

|Sep 24, 2022
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma.

Prapassorn Thirasastr, Heather Lin, Behrang Amini

Pageof 3